+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Cardiac Biomarkers Testing Market 2019-2025)

  • ID: 4801482
  • Report
  • Region: Asia, Asia Pacific
  • 104 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Johnson and Johnson
  • Quidel Corporation
  • Siemens AG
  • MORE
The Asia Pacific Cardiac Biomarkers Testing Market is expected to witness market growth of 12.8% CAGR during the forecast period (2019–2025).

Asia Pacific is expected to emerge as one of the most lucrative regions for Cardiac Biomarkers testing market. Prime factor fueling the growth of Asia Pacific region includes the presence of a large number of undiagnosed cardiac patients, rapid urbanization, rising disposable income, and growing awareness about cardiac disease management programs i.e. Quick cardiac checkup (QCC).

Preventing heart disease by tracking heart conditions through cardiac biomarker screening is the profound strategy for achieving rapid results for instant diagnosis and therapy. Cardiac biomarkers are traceable protein-based materials used as an indicator of the biological state and used for heart-related educational and prognostic reasons. Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infarction, congestive heart failure, acute coronary syndrome (ACS) among others. The cardiac biomarkers used widely as an integrated diagnostic approach for cardiovascular diseases include CK-MB, myoglobin, troponin I and T, BNPs, IMA, and many others.

Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.

Scope of the Study

Market Segmentation:

By Type
  • Creatine Kinase (CK-MB)
  • Troponins
  • Myoglobin
  • Natriuretic Peptides (BNP and NT-proBNP)
  • Ischemia Modified Albumin
  • Others
By Application
  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others
By Location of Testing
  • Point of Care Testing
  • Laboratory Testing
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Danaher Corporation
  • Johnson and Johnson
  • Quidel Corporation
  • Siemens AG
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Cardiac Biomarkers Testing Market, by Type
1.4.2 Asia Pacific Cardiac Biomarkers Testing Market, by Application
1.4.3 Asia Pacific Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 Asia Pacific Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint

Chapter 3. Asia Pacific Cardiac Biomarkers Testing Market by Type
3.1.1 Asia Pacific Creatine Kinase (CK-MB) Market by Country
3.1.2 Asia Pacific Troponins Market by Country
3.1.3 Asia Pacific Myoglobin Market by Country
3.1.4 Asia Pacific Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 Asia Pacific Ischemia Modified Albumin Market by Country
3.1.6 Asia Pacific Others Market by Country

Chapter 4. Asia Pacific Cardiac Biomarkers Testing Market by Application
4.1.1 Asia Pacific Myocardial Infarction Market by Country
4.1.2 Asia Pacific Congestive Heart Failure Market by Country
4.1.3 Asia Pacific Acute Coronary Syndrome Market by Country
4.1.4 Asia Pacific Atherosclerosis Market by Country
4.1.5 Asia Pacific Others Market by Country

Chapter 5. Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing
5.1.1 Asia Pacific Point of Care Testing Market by Country
5.1.2 Asia Pacific Laboratory Testing Market by Country

Chapter 6. Asia Pacific Cardiac Biomarkers Testing Market by Country
6.1 China Cardiac Biomarkers Testing Market
6.1.1 China Cardiac Biomarkers Testing Market by Type
6.1.2 China Cardiac Biomarkers Testing Market by Application
6.1.3 China Cardiac Biomarkers Testing Market by Location of Testing
6.2 Japan Cardiac Biomarkers Testing Market
6.2.1 Japan Cardiac Biomarkers Testing Market by Type
6.2.2 Japan Cardiac Biomarkers Testing Market by Application
6.2.3 Japan Cardiac Biomarkers Testing Market by Location of Testing
6.3 India Cardiac Biomarkers Testing Market
6.3.1 India Cardiac Biomarkers Testing Market by Type
6.3.2 India Cardiac Biomarkers Testing Market by Application
6.3.3 India Cardiac Biomarkers Testing Market by Location of Testing
6.4 South Korea Cardiac Biomarkers Testing Market
6.4.1 South Korea Cardiac Biomarkers Testing Market by Type
6.4.2 South Korea Cardiac Biomarkers Testing Market by Application
6.4.3 South Korea Cardiac Biomarkers Testing Market by Location of Testing
6.5 Singapore Cardiac Biomarkers Testing Market
6.5.1 Singapore Cardiac Biomarkers Testing Market by Type
6.5.2 Singapore Cardiac Biomarkers Testing Market by Application
6.5.3 Singapore Cardiac Biomarkers Testing Market by Location of Testing
6.6 Malaysia Cardiac Biomarkers Testing Market
6.6.1 Malaysia Cardiac Biomarkers Testing Market by Type
6.6.2 Malaysia Cardiac Biomarkers Testing Market by Application
6.6.3 Malaysia Cardiac Biomarkers Testing Market by Location of Testing
6.7 Rest of Asia Pacific Cardiac Biomarkers Testing Market
6.7.1 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Type
6.7.2 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Application
6.7.3 Rest of Asia Pacific Cardiac Biomarkers Testing Market by Location of Testing

Chapter 7. Company Profiles
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Trivitron Healthcare Pvt. Ltd.
  • Abbott Laboratories
  • Siemens AG
  • Becton, Dickinson AND Company
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Limited
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Johnson and Johnson
  • Quidel Corporation
Note: Product cover images may vary from those shown
Adroll
adroll